Eric Eldering
Eric Eldering
Academic Medical Center
Verified email at amc.uva.nl
Title
Cited by
Cited by
Year
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor–and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
MFM de Rooij, A Kuil, CR Geest, E Eldering, BY Chang, JJ Buggy, ...
Blood, The Journal of the American Society of Hematology 119 (11), 2590-2594, 2012
4562012
CD20 deficiency in humans results in impaired T cell–independent antibody responses
TW Kuijpers, RJ Bende, PA Baars, A Grummels, IAM Derks, KM Dolman, ...
The Journal of clinical investigation 120 (1), 214-222, 2010
3962010
miR-34a as part of the resistance network in chronic lymphocytic leukemia
T Zenz, J Mohr, E Eldering, AP Kater, A Bühler, D Kienle, D Winkler, ...
Blood 113 (16), 3801-3808, 2009
3052009
Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways
E Eldering, CA Spek, HL Aberson, A Grummels, IA Derks, AF de Vos, ...
Nucleic acids research 31 (23), e153-e153, 2003
2252003
The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells
NL Alves, IAM Derks, E Berk, R Spijker, RAW van Lier, E Eldering
Immunity 24 (6), 703-716, 2006
2102006
APRIL promotes B-1 cell-associated neoplasm
L Planelles, CE Carvalho-Pinto, G Hardenberg, S Smaniotto, W Savino, ...
Cancer cell 6 (4), 399-408, 2004
2012004
Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity
LA Smit, DYH Hallaert, R Spijker, B de Goeij, A Jaspers, AP Kater, ...
Blood 109 (4), 1660-1668, 2007
1952007
Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue
AM Grabiec, S Krausz, W de Jager, T Burakowski, D Groot, ME Sanders, ...
The journal of immunology 184 (5), 2718-2728, 2010
1892010
Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
WA Wuillemin, H Te Velthuis, YT Lubbers, CP De Ruig, E Eldering, ...
The journal of immunology 159 (4), 1953-1960, 1997
1441997
CD27–CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development
MF Van Oosterwijk, H Juwana, R Arens, K Tesselaar, MHJ Van Oers, ...
International immunology 19 (6), 713-718, 2007
1402007
c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches
DYH Hallaert, A Jaspers, CJ van Noesel, MHJ van Oers, AP Kater, ...
Blood, The Journal of the American Society of Hematology 112 (13), 5141-5149, 2008
1322008
The costimulatory molecule CD27 maintains clonally diverse CD8+ T cell responses of low antigen affinity to protect against viral variants
KPJM van Gisbergen, PL Klarenbeek, NAM Kragten, PPA Unger, ...
Immunity 35 (1), 97-108, 2011
1142011
CD20-induced B cell death can bypass mitochondria and caspase activation
LE Van der Kolk, LM Evers, C Omene, SMA Lens, S Lederman, ...
Leukemia 16 (9), 1735-1744, 2002
1142002
A hinge region mutation in C1-inhibitor (Ala436--> Thr) results in nonsubstrate-like behavior and in polymerization of the molecule.
KS Aulak, E Eldering, CE Hack, YP Lubbers, RA Harrison, A Mast, ...
Journal of Biological Chemistry 268 (24), 18088-18094, 1993
1131993
Modulation of Contact System Proteases by Glycosaminoglycans SELECTIVE ENHANCEMENT OF THE INHIBITION OF FACTOR XIa
WA Wuillemin, E Eldering, F Citarella, CP de Ruig, H ten Cate, CE Hack
Journal of Biological Chemistry 271 (22), 12913-12918, 1996
1121996
COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization
E Eldering, E Verpy, D Roem, T Meo, M Tosi
Journal of Biological Chemistry 270 (6), 2579-2587, 1995
1121995
Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation
WJM Mackus, AP Kater, A Grummels, LM Evers, B Hooijbrink, ...
Leukemia 19 (3), 427-434, 2005
1052005
CD40 stimulation of B‐cell chronic lymphocytic leukaemia cells enhances the anti‐apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic …
AP Kater, LM Evers, EBM Remmerswaal, A Jaspers, MF Oosterwijk, ...
British journal of haematology 127 (4), 404-415, 2004
1042004
Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia
M Jak, M Jak, R Mous, EBM Remmerswaal, R Spijker, A Jaspers, ...
Leukemia & lymphoma 50 (5), 788-801, 2009
1002009
Aptamer-targeted antigen delivery
BC Wengerter, JA Katakowski, JM Rosenberg, CG Park, SC Almo, ...
Molecular Therapy 22 (7), 1375-1387, 2014
99*2014
The system can't perform the operation now. Try again later.
Articles 1–20